🔗 Visit the ClinicalTrials.gov page for NCT05023759
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A brief measure for assessing generalized anxiety disorder: the GAD-7. | Arch Intern Med | 2006 | 21.56 |
| 2 | Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. | J Psychopharmacol | 2010 | 1.31 |
| 3 | Cannabidiol as a Potential Treatment for Anxiety Disorders. | Neurotherapeutics | 2015 | 0.84 |
| 4 | An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. | Cannabis Cannabinoid Res | 2017 | 0.75 |